{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T20:33:26Z","timestamp":1658349206727},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":905,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.jval.2010.09.005","type":"journal-article","created":{"date-parts":[[2011,3,13]],"date-time":"2011-03-13T08:36:45Z","timestamp":1300005405000},"page":"247-252","source":"Crossref","is-referenced-by-count":6,"title":["Health Care Use and Primary Prophylaxis with Colony-Stimulating Factors"],"prefix":"10.1016","volume":"14","author":[{"given":"Sean D.","family":"Sullivan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott D.","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David K.","family":"Blough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cara L.","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeannine S.","family":"McCune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jval.2010.09.005_bib1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJM199107183250305","article-title":"Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer","volume":"325","author":"Crawford","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jval.2010.09.005_bib2","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1001\/archinte.1988.00380120031007","article-title":"The medical course of cancer patients with fever and neutropenia","volume":"148","author":"Talcott","year":"1988","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jval.2010.09.005_bib3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00006454-199403000-00006","article-title":"Recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of febrile neutropenia: a double blind placebo-controlled study in children","volume":"13","author":"Riikonen","year":"1994","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jval.2010.09.005_bib4","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1002\/cncr.20983","article-title":"Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy","volume":"103","author":"Caggiano","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.jval.2010.09.005_bib5","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/00007890-199103000-00017","article-title":"Prophylaxis of bacterial infections with ciprofloxacin in patients undergoing bone marrow transplantation","volume":"51","author":"Lew","year":"1991","journal-title":"Transplantation"},{"key":"10.1016\/j.jval.2010.09.005_bib6","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/jac\/31.6.813","article-title":"Selective decontamination of the digestive tract and its role in antimicrobial prophylaxis","volume":"31","author":"Donnelly","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jval.2010.09.005_bib7","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1200\/JCO.1997.15.8.2981","article-title":"Clinical impact of chemotherapy dose escalation in patients with hematologic malignancies and solid tumors","volume":"15","author":"Savarese","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jval.2010.09.005_bib8","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1200\/JCO.1998.16.9.3179","article-title":"Design and interpretation of clinical trials that evaluate agents that may offer protection from the toxic effects of cancer chemotherapy","volume":"16","author":"Phillips","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jval.2010.09.005_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00663009","article-title":"Hematopoietic growth factors and treatment of testicular cancer: biological interactions, routine use and dose-intensive chemotherapy","volume":"72","author":"Bokemeyer","year":"1996","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jval.2010.09.005_bib10","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1200\/JCO.1998.16.2.716","article-title":"Filgrastim during combination chemotherapy of patients with poor-prognosis metastatic germ cell malignancy","volume":"16","author":"Fossa","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jval.2010.09.005_bib11","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1200\/JCO.2005.09.102","article-title":"First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study","volume":"23","author":"Vogel","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jval.2010.09.005_bib13","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1200\/JCO.2006.06.4451","article-title":"2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline","volume":"24","author":"Smith","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jval.2010.09.005_bib14","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.ejca.2006.05.002","article-title":"EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours","volume":"42","author":"Aapro","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jval.2010.09.005_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/jnci\/93.1.31","article-title":"Granulocyte colony-stimulating factor in the treatment of high-risk febrile neutropenia: a multicenter randomized trial","volume":"93","author":"Garcia-Carbonero","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jval.2010.09.005_bib16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3111\/13696990903238603","article-title":"Impact of primary prophylaxis on febrile neutropenia within community practices in the US","volume":"12","author":"Hershman","year":"2009","journal-title":"J Med Econ"},{"key":"10.1016\/j.jval.2010.09.005_bib17","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.clinthera.2009.05.019","article-title":"Risk of hospitalization for neutropenic complications of chemotherapy in patients with primary solid tumors receiving pegfilgrastim or filgrastim prophylaxis: a retrospective cohort study","volume":"31","author":"Weycker","year":"2009","journal-title":"Clin Ther"},{"key":"10.1016\/j.jval.2010.09.005_bib19","author":"Cross"},{"key":"10.1016\/j.jval.2010.09.005_bib23","first-page":"678","article-title":"Colony stimulating factor prescribing patterns in patients receiving chemotherapy for cancer","volume":"16","author":"Ramsey","year":"2010","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jval.2010.09.005_bib25","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.clinthera.2009.05.003","article-title":"Cost-effectiveness of pegfilgrastim versus filgrastim primary prophylaxis in women with early-stage breast cancer receiving chemotherapy in the United States","volume":"31","author":"Lyman","year":"2009","journal-title":"Clin Ther"},{"key":"10.1016\/j.jval.2010.09.005_bib26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1524-4733.2008.00434.x","article-title":"Cost-effectiveness of primary versus secondary prophylaxis with pegfilgrastim in women with early-stage breast cancer receiving chemotherapy","volume":"12","author":"Ramsey","year":"2009","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2010.09.005_bib27","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1200\/JCO.2000.18.7.1412","article-title":"Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII","volume":"18","author":"Crivellari","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jval.2010.09.005_bib28","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3109\/07357900009012191","article-title":"A prospective pharmacologic evaluation of age-related toxicity of adjuvant chemotherapy in women with breast cancer","volume":"18","author":"Dees","year":"2000","journal-title":"Cancer Invest"},{"key":"10.1016\/j.jval.2010.09.005_bib29","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1200\/JCO.1984.2.12.1404","article-title":"Cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in women more than 65 years old with advanced breast cancer: the elimination of age trends in toxicity by using doses based on creatinine clearance","volume":"2","author":"Gelman","year":"1984","journal-title":"J Clin Oncol"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301510000446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301510000446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T06:49:11Z","timestamp":1560062951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301510000446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S1098301510000446"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2010.09.005","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}